A newly developed, highly sensitive immunoassay for creatine kinase MB isoenzyme was evaluated in 68 patients with or without different types of ischaeimic heart disease. Patients were classified on the basis of clinical criteria in four groups: no ischaemic heart disease, stable angina, unstable angina, and acute myocardial infarction. Enzyme concentration in patients with stable angina was the same (even during exercise) as seen in the patients without ischaemic heart disease. Patients with unstable angina, however, could be divided into two groups. One group showed clear evidence of severe myocardial ischaemia by serial changes and higher mean values of creatine kinase MB up to 40 hours after the onset of symptoms, whereas in the remainder values were stable and resembled those seen in the patients without ischaemic heart disease. The changes in concentration correlated with signs of repetitive ischaemic episodes deduced from continuous ST segment monitoring during the first 24 hours after admission. These findings indicate that patients with unstable angina are a heterogenous group. In some, severe and prolonged ischaemia can be detected by a serological assay with high sensitivity.
We evaluated a newly developed, highly sensitive immunoassay for the creatine kinase isoenzyme MB in patients with ischaemic heart disease, with a view to classifying their disease on the basis of biochemical evidence of slight myocardial damage.
Patients and methods

PATIENTS
The study population consisted of 68 patients divided into four groups: 23 patients without ischaemic heart disease (group 1); 10 patients with stable angina pectoris (group 2); 21 patients with unstable angina (group 3); and 14 patients with acute myocardial infarction (group 4). The patients without ischaemic heart disease and patients with stable angina attended our outpatient clinic. Patients with stable angina were taking antianginal agents (long acting nitrates, calcium antagonists, or ,B blockers, or a combination of these drugs). Patients with unstable angina and acute myocardial infarction were recruited after admission to the coronary care unit within 12 hours of the development of retrosternal pain at rest. The mean time from onset of chest pain was 4 h 10 min (range 55 min-10 h 30 min) in patients with unstable angina and 3 h 35 min (range 1 h-10 h 30 min) in patients with acute myocardial infarction.
Eight (38.1%) of the 21 
PROCEDURE
After informed consent was obtained, long acting antianginal medication was stopped a week before the study in the patients with stable angina. The patients without ischaemic disease and with stable angina were exercised on bicycles-until exhaustion in patients without ischaemia and until both pain and ST depression of at least 01 mV occurred in patients with stable angina. Blood samples were drawn before and every 3-6 hours up to 24 hours after exercise. Blood samples were drawn from patients with acute myocardial infarction and unstable angina on admission and every 3-6 hours during the first 24 hours and then every eight hours up to 72 hours.
BLOOD SAMPLING Samples were drawn into tubes without anticoagulant through a catheter permanently placed in an antecubital vein. The samples were stored at +4 C for 15 minutes and then centrifuged at 3000 g for 10 minutes. The serum was stored at -21 C until analysis.
After thawing the serum was again centrifuged to remove any precipitate.
ANALYTICAL METHODS
The creatine kinase (EC 2.7.3.2) isoenzyme MB was measured by a newly developed and specially designed highly sensitive enzyme labelled immunosorbent assay (NovoClone CK-MB, Novo Biolabs, Cambridge, United Kingdom). Serum samples were simultaneously incubated with CK-B-specific antibodies attached to the polystyrene surface of the wells in a microtitration plate and with CK-M-specific antibodies conjugated with peroxidase. After one hour's incubation the microtitration plate was washed to remove non-adherent components and the remaining peroxidase activity was measured by an end point assay with orthophenyl diamine as the substrate. The incubation time was 15 minutes and the absorbance was read on an Archimedes plate reader (Novo, Copenhagen). We established a calibration curve using samples with concentrations of 1-30 jug/l. All controls, calibration samples, and clinical samples were analysed in quadruplicate and the figures averaged to minimise variability. Specimens containing more than 30 ,ug of creatine kinase MB per litre were reassayed by the same assay with a wider range of detectability.
In a previous study of 315 outpatients (132 men and 183 women) without myocardial diseases the reference interval was 0-6 jug/l. The overall median of the log gaussian distribution was 1 91 pig/l (2 03 jug/l for men and 1 79 ,ug/l for women). Total and within assay coefficient of variance was less than 6% at the upper reference limit. The detection limit was 01 mg/l. l0
The serum concentration of the creatine kinase B subunit was measured by an homogeneous enzyme immunoassay after inhibition of creatine kinase M-subunit activity." Figure 1 shows the mean values of serum creatine kinase MB concentration every three hours during the first 24 hours after exercise in the patients without ischaemic disease and in those with stable angina and during the first 72 hours after the onset of chest pain in patients with unstable angina or acute myocardial infarction. Because there was no difference between the mean concentrations of serum creatine kinase MB in patients without ischaemic heart disease and patients with stable angina we considered groups 1 and 2 together. The patients (group 3) with unstable angina had a higher mean concentration than this combination group from 3-6 hours to 21-24 hours (p < 0 05). Patients with acute myocardial infarction had significantly higher creatine kinase MB concentration than those with unstable angina from 3-6 hours to 64-72 hours (p < 0 01). To determine whether enzyme release occurs during exercise, serum concentrations of creatine kinase MB were measured before, immediately after, and one hour after an exercise test in patients without ischaemic heart disease and patients with stable angina. These Figure 3 Serum creatine kinase MB concentration (mean (SEM)) in UA (-) (0) and UA (+) (0) patients measured every 3-8 hours in the 72 hours after the onset of chest pain compared with mean concentration in the combined groups ofpatients without ischaemic heart disease or with stable angina (*) and patients with acute myocardial infarction (*).
concentrations resembled those measured 3-24 hours after exercise.
VARIABILITY OF SERUM CREATINE KINASE MB
There was considerable variation in the patients with acute myocardial infarction and in eight (38%) of the patients with unstable angina (fig 2) . In the group with unstable angina 13 (62%) patients had almost constant values (p < 0-01). The time course of changing enzyme concentrations in seven of the eight patients with enzyme fluctuation was similar to the curves obtained from patients with acute myocardial infarction. One patient had a different time course because the serum concentration of creatine kinase MB increased somewhat throughout the period of investigation. This patient had prolonged periods of chest pain, but did otherwise not differ from the others.
In figure 3 the mean concentrations of serum creatine kinase MB in the eight patients with unstable angina and enzyme changes UA( +) and the 13 patients with unstable angina and no enzyme changes UA(-) are compared with concentrations in the combined group (no ischaemic heart disease + stable angina) and the group with acute myocardial infarction. The UA( +) group had significantly higher mean values than the combined group in the interval from [3] [4] [5] [6] hours to 32-40 hours (p < 0 05). The UA (-) group did not differ from the combined group. The UAP (+) group had a creatine kinase MB concentration curve that resembled that of the patients with acute myocardial infarction but the concentration was significantly lower in the interval from [3] [4] [5] [6] hours to 32-40 hours (p < 0 05). There was an earlier peak of serum creatine kinase MB in the UA (+) group than in the patients with acute myocardial infarction.
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COMPARISON WITH CREATINE KINASE-B Figure 4 shows that the mean serum creatine kinase-B residual activity was similar in the UA (+) and UA (-) patients. In the group with unstable angina, however, segment depression or elevation > 001 mV or our results indicate that the grade of unstable T wave inversion, or both) were found at angina may reflect the degree of myocardial admission in six (46%) of 13 patients with UA damage. Some of the patients with unstable (-) and in seven (88%) of eight patients with angina showed clear evidence of ischaemic UA (+). The difference was not statistically injury-serial changes and higher mean values significant (p = 0 27).
of serum creatine kinase MB concentrationafter the onset of symptoms than a reference CREATINE KINASE MB AND ST SEGMENT CHANGES group of patients without ischaemic heart dis-IN PATIENTS WITH UNSTABLE ANGINA ease or with stable angina. In addition, fluctuaTwenty of the 21 patients with unstable angina tions in creatine kinase MB correlated with had ST segment analysis by Holter monitoring evidence of repetitive ischaemic episodes on during the first 24 hours after admission. There continuous ST segment monitoring during the were episodes of significant ST segment de-first 24 hours after admission. pression in six of 12 patients with UA (-) but
Whether enzyme release is due to minor in all patients with UA (+). There was a necrosis of myocardial tissue or severe but significant association between the presence of reversible ischaemic injury cannot be deterreversible ST segment depression and serum mined from the present study. Enzyme leakage enzyme fluctuation (p < 0 05).
has been found under experimental conditions in ischaemically damaged myocardial tissue CREATINE KINASE MB AND IN-HOSPITAL without signs of irreversible myocardial CLINICAL OUTCOME injury. On the other hand, studies of The presence of ischaemic heart disease was patients suggested that slight increases in confirmed by either an exercise test or coronary serum concentrations of creatine kinase and angiography in all patients with unstable creatine kinase B were caused by microangina. No patients with unstable angina with-necroses.22 This is supported by techniques out enzyme changes had coronary events dur-such as myocardial scintigraphy with teching their hospital stay. Two patients with netium-99m-pyrophosphate and necropsy unstable angina and enzyme changes later had studies.2324 an acute myocardial infarction during their
In patients with unstable angina serum hospital stay.
creatine kinase MB concentrations were only slightly raised and the time course of the Discussion increase in creatine kinase MB resembled the The results of the present study indicate that curves obtained from patients with acute the new creatine kinase MB immunoassay is a myocardial infarction. This suggests that promising diagnostic tool because it may help patients with unstable angina had minimal to determine the frequency and severity of myocardial necrosis. The earlier rise in peak myocardial ischaemic events in the different creatine kinase MB in unstable angina resemcoronary syndromes. Until now assessment of bled the enzyme course described in patients damage to the ischaemic myocardium by with non-Q wave infarction and has led to the measurement of creatine kinase isoenzymes has hypothesis that reperfusion is likely to occur in mainly been based upon analysis of creatine patients with non-Q wave acute myocardial kinase B by immunochemical methods or infarction.25 Reperfusion is also likely to occur creatine kinase MB by electrophoretic or after transient non-perfusion in unstable chromatographic methods."2"4 These methods angina. However, the UA (+) patients did not are satisfactory for diagnosing acute myo-have acute myocardial ischaemia by the classic cardial infarction but they are less sensitive for World Health Organisation criteria.9 Findings monitoring continuing myocardial ischaemia. were similar when serum myoglobin was used Creatine kinase MB specific enzyme linked as a marker of myocardial ischaemia in a group immunoadsorbent assays have a high sensiti-of patients with an acute ischaemic myocardial vity.""'8 This method has been further insult.26 Therefore the gradation of patients improved by using a double antibody tech-with unstable angina implies the identification nique, which gives a highly specific and sen-of a subgroup with small size myocardial necrosis. The various time courses of creatine kinase MB within this population (fig 2) further indicate that this enzymatic marker of myocardial ischaemia need not be restricted to conventional myocardial infarction. It also reflects-in time and degree-the range of ischaemic damage of myocardial tissue. In this context the present results confirm that myocardial infarction and enzyme release are not all-or-non processes, but rather a continuum dependent on the duration and intensity of ischaemia and on the condition of the myocardium at the onset of the ischaemic episode.2"'8 
